Claybrook Capital’s ETRACS Alerian MLP Index ETN Series B due July 18 2042 AMUB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-18,658
Closed -$356K 131
2021
Q4
$356K Hold
18,658
0.17% 109
2021
Q3
$354K Buy
+18,658
New +$213K 0.18% 105

Other funds holding AMUB

Claybrook Capital's AMUB Position: Q1 2022 in Review

Claybrook Capital sold out of ETRACS Alerian MLP Index ETN Series B due July 18 2042 (AMUB) in Q1 2022, closing a stake of 18,658 shares — an estimated $356K sold.

Claybrook Capital first reported a position in AMUB in Q3 2021 and held it in 2 quarters. The position peaked at $356K in Q4 2021. 9 funds tracked by Wall St. Rank hold AMUB as of Q1 2022.

  • Claybrook Capital reported no remaining ETRACS Alerian MLP Index ETN Series B due July 18 2042 position as of Q1 2022 after selling out during the quarter.
  • Claybrook Capital sold 18,658 ETRACS Alerian MLP Index ETN Series B due July 18 2042 shares in Q1 2022, an estimated $356K.
  • Claybrook Capital first reported a position in ETRACS Alerian MLP Index ETN Series B due July 18 2042 in Q3 2021 and held it in 2 quarters.
  • Claybrook Capital's ETRACS Alerian MLP Index ETN Series B due July 18 2042 position peaked at $356K in Q4 2021.
  • 9 funds tracked by Wall St. Rank held ETRACS Alerian MLP Index ETN Series B due July 18 2042 as of Q1 2022.

Based on Claybrook Capital's 13F filing for Q1 2022, filed 6 May 2022.